Altimmune Inc (ALT)

[chmcnfunds]

FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine

Apr. 25, 2018 9:45 AM ET|By: Douglas W. House, SA News Editor

The FDA accepts for review Sanofi Pasteur's (SNY +0.6%) supplemental marketing application seeking approval to use the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) in children ages six months to 35 months. It is is currently approved for use in kids at least 36 months of age.

The agency's action date is January 28, 2019.

Flu vaccine-related tickers: (ALT)(GSK -3.8%)(AZN -0.4%)(BVXV)
_______________________________________________
https://seekingalpha.com/news/3348542-fda-accepts-sanofi-pasteurs-marketing-application-expanded-use-flu-vaccine?app=1&uprof=46#email_link

ALT